Accueil   Diary - News   All news Adocia receives Deloitte price

Adocia receives Deloitte price

Adocia receives the Deloitte In Extenso Technology Fast 50 Prize in the “Listed Company” category for the Grand Rhône-Alpes region

 

Adocia, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, especially insulins for diabetes treatment, announces that it received the “Listed Company” prize for the Grand Rhône-Alpes region during the 15th Deloitte In Extenso Technology Fast 50 event in Lyon.

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree